BCA
CBIO

Berman Capital Advisors’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Berman Capital Advisors’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11
Closed -$3K – 1952
2021
Q1 		$3K Sell
11
-1
-8% -$273 ﹤0.01% 1416
2020
Q4 		$4K Hold
12
– – ﹤0.01% 1218
2020
Q3 		$3K Hold
12
– – ﹤0.01% 1191
2020
Q2 		$4K Buy
+12
New +$4K ﹤0.01% 1052